Skip to main content

Advertisement

ADVERTISEMENT

Asthma News

News
09/23/2022
“This study highlights the potential of a digital health tool to support asthma management and physician-patient interactions and discussions around inhaler technique and adherence," researchers said.
“This study highlights the potential of a digital health tool to support asthma management and physician-patient interactions and discussions around inhaler technique and adherence," researchers said.
“This study highlights the...
09/23/2022
First Report Managed Care

Advertisement

News
09/02/2022
“Insight into the impact of adherence on the burden of asthma is important for health care stakeholders and can assist in directing future efforts to improve clinical and economic outcomes for patients with asthma,” said researchers.
“Insight into the impact of adherence on the burden of asthma is important for health care stakeholders and can assist in directing future efforts to improve clinical and economic outcomes for patients with asthma,” said researchers.
“Insight into the impact of...
09/02/2022
First Report Managed Care
News
08/25/2022
An analysis showed agents that target interleukins are significantly associated with reduced rates of asthma exacerbation for patients with severe disease.
An analysis showed agents that target interleukins are significantly associated with reduced rates of asthma exacerbation for patients with severe disease.
An analysis showed agents that...
08/25/2022
First Report Managed Care
News
08/03/2022
Findings showed dupilumab treatment improved lung function and reduced the impact of exacerbations on lung function in patients with moderate to severe type 2 asthma.
Findings showed dupilumab treatment improved lung function and reduced the impact of exacerbations on lung function in patients with moderate to severe type 2 asthma.
Findings showed dupilumab...
08/03/2022
First Report Managed Care

Advertisement

News
06/30/2022
Patients experienced improvements in asthmatic symptoms, lung function, and fractional exhaled nitric oxide after treatment with a monoclonal antibody.
Patients experienced improvements in asthmatic symptoms, lung function, and fractional exhaled nitric oxide after treatment with a monoclonal antibody.
Patients experienced...
06/30/2022
First Report Managed Care
News
06/10/2022
Researchers identified unmet need in US patients with severe asthma who have residual disease despite the use of biologics. 
Researchers identified unmet need in US patients with severe asthma who have residual disease despite the use of biologics. 
Researchers identified unmet...
06/10/2022
First Report Managed Care
News
04/19/2022
Patients maintained low asthma exacerbation rates and reduced oral corticosteroid use after long-term treatment with a monoclonal antibody, findings showed.
Patients maintained low asthma exacerbation rates and reduced oral corticosteroid use after long-term treatment with a monoclonal antibody, findings showed.
Patients maintained low asthma...
04/19/2022
First Report Managed Care

Advertisement

News
02/24/2022
Authors of an indirect treatment comparison found that dupilumab improved asthma severity more than other biologics such as benralizumab and omalizumab. 
Authors of an indirect treatment comparison found that dupilumab improved asthma severity more than other biologics such as benralizumab and omalizumab. 
Authors of an indirect treatment...
02/24/2022
First Report Managed Care
News
12/28/2021
Recent data shows education levels, race/ethnicity, and preferred language significantly correlate with a parent’s self-management knowledge when seeking asthma care for their children.
Recent data shows education levels, race/ethnicity, and preferred language significantly correlate with a parent’s self-management knowledge when seeking asthma care for their children.
Recent data shows education...
12/28/2021
First Report Managed Care
News
12/22/2021
Biologics significantly reduced exacerbation rates of severe persistent eosinophilic asthma compared to placebo, according to a network meta-analysis.
Biologics significantly reduced exacerbation rates of severe persistent eosinophilic asthma compared to placebo, according to a network meta-analysis.
Biologics significantly reduced...
12/22/2021
First Report Managed Care

Advertisement

Advertisement